期刊文献+

小檗碱联合甲磺酸阿帕替尼对肝癌Hep-G2细胞增殖和凋亡及周期的影响 被引量:7

Effects of Apatinib Mesylate Combined with Berberine on the Proliferation, Cell Cycle Distribution and Apoptosis of Hep-G2 Cells
下载PDF
导出
摘要 目的研究甲磺酸阿帕替尼、小檗碱及两药联合对Hep-G2细胞增殖、周期分布、凋亡的影响,探讨其抗肿瘤机制。方法 CCK-8法检测甲磺酸阿帕替尼、小檗碱及两药联合对Hep-G2细胞增殖的抑制作用;流式细胞术检测甲磺酸阿帕替尼、小檗碱及两药联合对细胞周期分布、细胞凋亡的影响。结果甲磺酸阿帕替尼及小檗碱对Hep-G2细胞均具有增殖抑制作用,且呈现浓度、时间依赖性;其25%抑制浓度(IC25)值分别为0.5,30μmol·L^-1;两药联合时,Hep-G2的增殖抑制率也呈时间依赖性(P<0.05);甲磺酸阿帕替尼干预Hep-G2后G0/G1期细胞增加,S期及G2/M期细胞减少,小檗碱干预Hep-G2后G2/M期细胞增加,G0/G1期及S期细胞减少,两药联合干预后G0/G1期细胞明显增加,S期及G2/M期细胞减少(P<0.01);甲磺酸阿帕替尼、小檗碱干预Hep-G2细胞均可促进细胞凋亡,凋亡率与药物作用时间呈正相关,两药联合时,细胞凋亡率进一步提高(P<0.05)。甲磺酸阿帕替尼、小檗碱均可抑制Hep-G2细胞增殖,且呈时间-浓度依赖性,当两药联合时其增殖抑制作用进一步加强,呈现出时间依赖性。结论甲磺酸阿帕替尼、小檗碱均可阻滞细胞周期、促进细胞凋亡,且均呈现时间依赖性,两药联合时效果更明显。 Objective To study the effects of apatinib mesylate, berberine and combination two drugs on the proliferation, cell cycle distribution and apoptosis of Hep-G2 cells, and to explore the mechanism. Methods CCK-8 method was used to detect the inhibitory effect of the treatments;Cell cycle distribution and apoptosis were detected by flow cytometry. Results Apatinib mesylate and berberine had a certain inhibitory effect on the proliferation of Hep-G2 cells, and both showed a concentration and time dependence manner;their IC25 values were 0.5 μmol·L-1 and 30 μmol·L-1, respectively.When the two drugs were combined, the proliferation inhibition rate of Hep-G2 was also time-dependent after apatinib mesylate treatment, the proportion of cells in G0/G1 phase increased, and the proportion of cells in S phase and G2/M phase decreased.After berberine treatment, the proportion of cells in G2/M phase increased, and the proportion of cells in G0/G1 phase and S phase decreased when combined two drugs to treat Hep-G2 cells, the proportion of cells in G0/G1 phase increased significantly, while the proportion of cells in S phase and G2/M phase decreased(P<0.01);Both of apatinib mesylate and berberine could induce apoptosis in Hep-G2 cells in a time-dependent manner;And the rate of apoptosis was further enhanced by the combination use of two drugs(P<0.05).Both apatinib mesylate and berberine inhibited the proliferation of Hep-G2 cells in a time-concentration dependent manner, and the proliferation inhibition was further strengthened when the two drugs were combined, which also showed a time-dependent effect. Conclusion Apatinib mesylate and berberine can both cause cell cycle arrest and promote apoptosis in a time-dependent manner, and the effect is more obvious when the two drugs are combined.
作者 谢俊杰 邓波 易峰涛 邵志雄 徐振华 XIE Junjie;DENG Bo;YI Fengtao;SHAO Zhixiong;XU Zhenhua(Department of Radiotherapy, GeneralHospital of Central Theater Command of Chinese People's Liberation Army, Wuhan 430070, China;Center of Cancer, Xianning Central Hospital, Hubei Province,Xianning 437000, China)
出处 《医药导报》 CAS 北大核心 2019年第11期1414-1418,共5页 Herald of Medicine
基金 中国博士后自然科学基金资助项目(2013M542581)
关键词 甲磺酸阿帕替尼 小檗碱 肝癌 细胞增殖 细胞周期 细胞凋亡 Apatinib,mesylate Berberine Hepatocellular carcinoma Cell proliferation Cell cycle Apoptosis
  • 相关文献

参考文献10

二级参考文献75

  • 1Jing-Pin Lin,Jai-Sing Yang,Jau-Hong Lee,Wen-Tsong Hsieh,Jing-Gung Chung.Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line[J].World Journal of Gastroenterology,2006,12(1):21-28. 被引量:36
  • 2lizuka N, Hazama S, Yoshimura K, et al. Anticachecfic effects of the natural herb Coptidis rhizo ma and berberine on mice bearing co Ion 26/clone 20 adenocarcinoma[J]. Int J Cancer, 2002, 99 (2) :286-291.
  • 3Fukuda K, Hibiya Y, Mutoh M, et al. Inhibition of activator prot- ernl activity by berberine in human hepatoma cells [ J]. Planta Med, 1999, 65(4) :381-383.
  • 4Assadian S, Teodoro JG. Regulation of collagen-derived antiangiogen- ic factors by p53[J]. Expert Opio Biol Ther, 2008, 8(7) :941-950.
  • 5Stepensky D, Tzehoval E, Vadai E, et al. O-glycosylated versus nonglyeosylated MUCl-dcrived peptides as potential targets for cy- totoxic immunotherapy of carcinoma [ J ]. Clin Exp Immunol, 2006, 143( 1 ) :139-149.
  • 6DI DOMENICO M, RICCIARDI C, FUSCP A, et al. Anti- VEGF therapy in breast and lung mouse models of cancers [J].J Biomed Biotechnol, 2011,2011 : 947-928.
  • 7PENG P L,KUO W H,TSENG H C,et al. Synergistic tumor-killing effect of radiation and berberine com- bined treatment in lung cancer: the contribution of au- tophagic cell death[J]. In J Radiat Oncol Biol Phys, 2006,70 : 529-- 542.
  • 8PANG R W, POON R T. From molecular biology to targeted therapies for hepatocelluIar carcinoma:the fu- ture is now[J]. Oncology, 2007,72(suppl 1) : 30--44.
  • 9YU H B, ZHANG H F, ZHANG X, et al. Resveratrol inhibits VEGF expression of human hepatocellular car- cinoma cells through a NF-kappa B-mediated meeha- nism[J]. Hepatogastroenterology, 2010,57 (102-103) : 1241--1246.
  • 10GRETEN T F, KORANGY F, MANNS M P, et al. Molecular therapy for the treatment of hepatocellular carcinoma[J]. British J Cancer, 2009,100 : 19- 23.

共引文献111

同被引文献73

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部